About Carisma Therapeutics, Inc. - Common Stock (CARM)
Carisma Therapeutics, Inc. is a biotechnology company focused on the development of innovative cell therapies for the treatment of cancer and other diseases. The company specializes in harnessing the power of engineered immune cells, particularly macrophages, to target and destroy tumor cells more effectively. By utilizing advanced genetic engineering techniques, Carisma aims to enhance the body's immune response against cancer, striving to improve patient outcomes and provide novel treatment options for patients with various malignancies. Through research and clinical development, Carisma is dedicated to advancing its therapies toward commercialization and transforming cancer care. Read More
Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Carisma Therapeutics Inc. (NASDAQ: CARM) and OrthoCellix, Inc. is fair to Carisma shareholders. Upon completion of the proposed transaction, existing Carisma shareholders are expected to own approximately 10% of the combined company.
PHILADELPHIA and MALVERN, Pa., June 23, 2025 (GLOBE NEWSWIRE) -- Carisma Therapeutics Inc. (Nasdaq: CARM) (Carisma) and OrthoCellix, Inc. (OrthoCellix), a wholly-owned subsidiary of Ocugen, Inc. (Nasdaq: OCGN) (Ocugen), a clinical-stage company developing regenerative cell therapies for orthopedic diseases, today jointly announced that they have entered into a definitive merger agreement to combine the companies in an all-stock transaction. The combined company will focus on the development of OrthoCellix’s NeoCart® technology for the treatment of knee articular cartilage defects and plans to initiate a U.S. Food and Drug Administration (FDA)-endorsed Phase 3 clinical trial for NeoCart®.
The regular session of the US market on Friday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Stay up-to-date with the latest market trends one hour before the close of the markets on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top gainers and losers in today's session.
Let's have a look at what is happening on the US markets before the opening bell on Tuesday. Below you can find the top gainers and losers in today's pre-market session.
As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
Let's have a look at what is happening on the US markets after the closing bell on Friday. Below you can find the top gainers and losers in today's after hours session.
